Investor Overview We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Intersect ENT's financial performance into perspective. Financial Releases Jan 25, 2022 Summary ToggleReal-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization Nov 02, 2021 Summary ToggleIntersect ENT Reports Third Quarter 2021 Financial Results View all financial releases » Events & Presentations More events are coming soon. View all events & presentations »